ALLR

Companies
NASDAQ
Allarity Therapeutics Inc.
Health Care
Price Chart
Overview

About ALLR

oncology venture is a drug development company formed in 2012 dedicated to unlock the potential of new oncology products, and rescue failed drugs. our method improves the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and improve success rates in oncology drug development.

Market Cap
$8.8M
Volume
565.0K
Avg. Volume
960.1K
P/E Ratio
-0.02344416
Dividend Yield
0.00%
Employees
7.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.57
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for ALLR.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, ALLR shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$8.8M
Volume565.0K
P/E Ratio-0.02
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
November 14, 2023
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how ALLR fits into your investment strategy and portfolio diversification.

Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025